Neofect Co.Ltd - Asset Resilience Ratio

Latest as of September 2025: 0.48%

Neofect Co.Ltd (290660) has an Asset Resilience Ratio of 0.48% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does Neofect Co.Ltd carry for a breakdown of total debt and financial obligations.

Liquid Assets

₩333.62 Million

≈ $226.09K USD Cash + Short-term Investments

Total Assets

₩69.30 Billion

≈ $46.97 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how Neofect Co.Ltd's Asset Resilience Ratio has changed over time. See Neofect Co.Ltd (290660) shareholders funds for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Neofect Co.Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Neofect Co.Ltd stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩333.62 Million	0.48%
Total Liquid Assets	₩333.62 Million	0.48%

Asset Resilience Insights

Limited Liquidity: Neofect Co.Ltd maintains only 0.48% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Neofect Co.Ltd Industry Peers by Asset Resilience Ratio

Compare Neofect Co.Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Shenzhen New Industries Biomedical SHE:300832	Medical Devices	9.95%
Jafron Biomedical Co Ltd SHE:300529	Medical Devices	36.63%
Zhejiang Orient Gene Biotech Co Ltd SHG:688298	Medical Devices	2.82%
Shanghai ZJ Bio-Tech Co. Ltd. A SHG:688317	Medical Devices	9.52%
Guangdong Transtek Medical Electronics Co Ltd SHE:300562	Medical Devices	14.72%
Emvision Medical Devices Ltd AU:EMV	Medical Devices	0.47%
DRGEM Corporation KQ:263690	Medical Devices	0.50%
Diagnostic Medical Systems SA PA:ALDMS	Medical Devices	1.39%

Annual Asset Resilience Ratio for Neofect Co.Ltd (2016–2024)

The table below shows the annual Asset Resilience Ratio data for Neofect Co.Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	37.35%	₩27.03 Billion ≈ $18.32 Million	₩72.36 Billion ≈ $49.04 Million	+4.46pp
2023-12-31	32.89%	₩23.59 Billion ≈ $15.99 Million	₩71.71 Billion ≈ $48.60 Million	+29.84pp
2022-12-31	3.05%	₩1.54 Billion ≈ $1.04 Million	₩50.37 Billion ≈ $34.14 Million	-8.00pp
2021-12-31	11.05%	₩5.80 Billion ≈ $3.93 Million	₩52.54 Billion ≈ $35.61 Million	-13.75pp
2020-12-31	24.80%	₩14.36 Billion ≈ $9.73 Million	₩57.91 Billion ≈ $39.24 Million	+5.47pp
2019-12-31	19.33%	₩9.09 Billion ≈ $6.16 Million	₩47.02 Billion ≈ $31.86 Million	-42.92pp
2018-12-31	62.25%	₩22.36 Billion ≈ $15.15 Million	₩35.92 Billion ≈ $24.34 Million	+23.74pp
2017-12-31	38.51%	₩3.93 Billion ≈ $2.66 Million	₩10.21 Billion ≈ $6.92 Million	-19.32pp
2016-12-31	57.83%	₩4.59 Billion ≈ $3.11 Million	₩7.93 Billion ≈ $5.38 Million	--

pp = percentage points

About Neofect Co.Ltd

KQ:290660 Korea Medical Devices

Market Cap

$39.65 Million

₩58.50 Billion KRW

Market Cap Rank

#22703 Global

#1556 in Korea

Share Price

₩1159.00

Change (1 day)

+1.13%

52-Week Range

₩664.00 - ₩1700.00

All Time High

₩7354.13